Bayer AG (FRA:BAYN) has been given a €124.00 ($145.88) price objective by research analysts at Commerzbank Ag in a research report issued on Friday. The firm currently has a “buy” rating on the healthcare company’s stock.

A number of other research firms have also recently issued reports on BAYN. UBS AG set a €125.00 ($147.06) target price on Bayer AG and gave the stock a “buy” rating in a report on Tuesday, June 27th. J P Morgan Chase & Co set a €125.00 ($147.06) target price on Bayer AG and gave the stock a “buy” rating in a report on Monday, July 3rd. Baader Bank set a €120.00 ($141.18) target price on Bayer AG and gave the stock a “neutral” rating in a report on Monday, July 3rd. BNP Paribas set a €103.00 ($121.18) target price on Bayer AG and gave the stock a “neutral” rating in a report on Monday, July 3rd. Finally, Deutsche Bank AG set a €124.00 ($145.88) target price on Bayer AG and gave the stock a “buy” rating in a report on Monday, July 24th. Eight equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Bayer AG has a consensus rating of “Buy” and an average price target of €121.68 ($143.16).

COPYRIGHT VIOLATION WARNING: This article was published by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/10/13/commerzbank-ag-analysts-give-bayer-ag-bayn-a-124-00-price-target.html.

Bayer AG Company Profile

.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.